Drawing for Serial No. 79003822

USPTO serial 79003822

Serial No. 79003822

Reviewed by CopyMark Law Group

Reg. 3004591Status 404
Filing date
Status date
Registration date
Oct 4, 2005
Examiner
SUAREZ, MARIA VICTORIA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79003822?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sang Eun Lee

Sang Eun Lee Greenberg Traurig, LLP2200 Ross Avenue, Suite 5200Dallas, TX 75201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; adhesives, other than for stationery or household purposes; plant growth regulating preparations; fertilizers; [ ceramic glazings; higher fatty acids used in the chemical industry; non-metallic minerals, namely, sulphur, foundry sand, kaolin, talc, rock salt, diatomaceous earth, acid clay, barytes and heavy spar, saltpeter, natural graphite, dolomite, cryolite, bentonite, bauxite, fluorite, magnesite, alunite, and rock phosphate, all used for chemical industry; photographic chemicals; photographic paper; unexposed photographic film; ] chemical test paper; [ artificial sweeteners; wood flour and plant flour for use as a filler in the manufacture of plastics; starch for industrial purposes; ] plastics in primary form, namely, unprocessed plastics; [ wood pulp, paper pulp and ] synthetic pulp for manufacturing purposesSECTION 70 - CANCELLED—
005[ Pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparation sand substances; pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations namely, anticoagulants, pharmaceutical preparations namely,antidepressants; pharmaceutical preparations namely, appetite suppressants; pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;] pharmaceutical preparations for animal skin care; [ pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; ] pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds; [ pharmaceutical product sand preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use;] pharmaceutical products for skin care for animals; [ pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; veterinary preparations, namely, pain relief medication; ] all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic and agricultural use, herbicides for domestic and agricultural use; [ veterinary preparations for treatment of intestinal bacteria; veterinary vaccine for horses; veterinary vaccines; veterinary vaccines for bovine, sheep, horse, cat, dog, chicken; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes; ] sanitary preparations for medical purposes, namely, sanitizers for hospital and household use and for use in institutional and industrial areas; chemical preparations for sanitary use; sanitary sterilizing preparations; deodorants other than for personal use, namely, air deodorant, car deodorant, and household deodorant; [ dietetic substances adapted for medical use, namely, bee pollen for use as a dietary food supplement, dietary drink mix for use as a meal replacement, dietary food supplements, dietary supplemental drinks, dietary supplements, lecithin for use as a dietary supplement, meal replacement and dietary supplement drink mixes, nutraceuticals for use as a dietary supplement, and wheat for use as a dietary supplement; ] oiled paper for medical purposes; [ pharmaceutical wafer made out of starches in papery membrane for wrapping a dose of powdered medicine;] gauze for dressings; unit dose capsules sold empty for pharmaceutical use; eye patches; adhesive ear bandages; menstruation bandages; menstruation tampons; sanitary napkins sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; collodion for medical purposes; breast-nursing pads; dental composite materials; dental impression materials; [ bracelets for medical purposes; ] incontinence diapers; fly catching paper; mothproofing paper; [ nutritional supplement in the nature of lactose; powdered milk for babies; semen for artificial insemination ]SECTION 70 - CANCELLED—
006[ Metal bars for further manufacture; nickel ores; zinc ores ]SECTION 71 - CANCELLED—
010[ Sanitary masks for medical purposes ]SECTION 71 - CANCELLED—
017Raw or partly processed mica; valves of rubber or vulcanized fiber not including machine elements; non-metal gaskets used in medical, construction, automobile, shipping, chemical, mechanical, electrical and battery industries, and also for household purposes; junctions not of metal for pipes, used for the purpose of insulation, joint-couplings and plumbing purposes; packing material for forming seals; packing padding of plastic for shipping containers; rubber packing for shipping containers; fire hoses; asbestos fire curtains; floating anti-pollution barriers; electrical insulating materials; washers of rubber or vulcanized fiber used in medical, construction, automobile, shipping, chemical, mechanical, electrical and battery industries, and also for household purposes; non-metal horseshoes; chemical fiber not for textile use; [ asbestos boards; asbestos packing for valves; asbestos powder; rock wool; slag wool for use as a building insulator; rubber thread and covered rubber yarn not for textile use; ] chemical fiber yarn and thread not for textile use; [ asbestos yarn; asbestos fabrics; asbestos felt; ] insulating gloves; [ rubber cords and laces; asbestos cords and strings; asbestos nets; ] industrial packaging containers of rubber; rubber stoppers for industrial packaging containers; [ rubber lids and caps for industrial packaging containers; ] plastic sheeting for agricultural purposes; condenser paper; [ asbestos paper; ] vulcanized fiber; plastics in the form of bars, blocks, pellets, rods, sheets and tubes for use in manufacturing; [ raw and semi-worked rubber; soundproofing materials of rock wool not for building purposes; asbestos boards; asbestos powder ]SECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 13, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 23, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 7, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 7, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 7, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 7, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 7, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 7, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 11, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 11, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 10, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 10, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Nov 10, 201571AGREGISTERED-SEC.71 ACCEPTED—
Nov 10, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2015ES71TEAS SECTION 71 RECEIVED—
Dec 18, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 4, 2014LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Feb 27, 2014RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 21, 2014LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 21, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 12, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 12, 2013INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 12, 2013INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 13, 2012INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 13, 2012NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 13, 2011C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 26, 2011715FREGISTERED - SEC. 71 & SEC. 15 FILED—
Sep 26, 2011ES71TEAS SECTION 71 RECEIVED—
Sep 26, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 22, 2011E15RTEAS SECTION 15 RECEIVED—
Sep 1, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 11, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 11, 2006FIMPFINAL DISPOSITION PROCESSED—
Jun 19, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 4, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 12, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2005NPUBNOTICE OF PUBLICATION—
Apr 6, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 1, 2005ALIEASSIGNED TO LIE—
Mar 31, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 31, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 3, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2005MAILPAPER RECEIVED—
Dec 14, 2004ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2004REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 8, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 8, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2004DOCKASSIGNED TO EXAMINER—
Aug 16, 2004NWAPNEW APPLICATION ENTERED—
Aug 12, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance